Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777751 · ClinicalTrials.gov registry record
Radiation Therapy and Cardiac Enzymes
A clinical trial of Tumor, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00777751: Completed study of Tumor, sponsored by M.D. Anderson Cancer Center.
NCT00777751 is a study of Tumor that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants, below the 183-participant average among 18 other Tumor trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777751, a study of Tumor, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn if the radiation that you are receiving will result in an increase in certain proteins produced by the heart called cardiac biomarkers.
Conditions Studied
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-10-06 |
| Est. Completion | 2016-11-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00777751
The ClinicalTrials.gov registry entry for NCT00777751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 18 other Tumor trials with a reported enrollment target (84% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT00777751 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00777751 about?
NCT00777751 is a clinical study titled "Radiation Therapy and Cardiac Enzymes". The goal of this clinical research study is to learn if the radiation that you are receiving will result in an increase in certain proteins produced by the heart called cardiac biomarkers.
What is the current status of trial NCT00777751?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-10-06. Estimated completion is 2016-11-21.
What conditions does trial NCT00777751 study?
This clinical trial studies the following conditions: Tumor.
Who is sponsoring clinical trial NCT00777751?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00777751 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Decoupling Immunotherapy Toxicity and Cancer Response
RECRUITING
-
A Study of Live Tumor Fragments of Surgical Resections
RECRUITING
-
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
RECRUITING · Phase 2
-
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
RECRUITING · Phase 2
-
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
RECRUITING · Phase 2
-
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.